Global Interventional Oncology Ablation Market- Regional Analysis
Among regions, North America is estimated to hold a dominant position in the global interventional oncology ablation market over the forecast period. North America is estimated to hold 33.5% of the market share in 2023. Increasing product approvals by regulatory authorities are contributing to the growth of the global interventional oncology ablation market in the North America region. For instance, in September 2021, Novian Health Inc. a biotechnology company was granted Breakthrough Device designation from the U.S. Food and Drug Administration for its Novilase Interstitial Laser System and its proposed indication for use in focal destruction of malignant breast tumors in adult women who seek a breast conserving procedure.
Interventional Oncology Ablation Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients